North America Veterinary Medicine Market – Industry Trends and Forecast to 2032

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Pharmaceutical North America Veterinary Medicine Market
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

North America Veterinary Medicine Market – Industry Trends and Forecast to 2032

  • Pharmaceutical
  • Apr 2025
  • North America
  • 350 Pages
  • No of Tables: 448
  • No of Figures: 40
Buy Now Buy Now Request for Sample Request for Sample
Nucleus Nucleus

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

North America Veterinary Medicine Market

Market Size in USD Billion

CAGR :  % Diagram

Bar chart comparing the North America Veterinary Medicine Market size in 2024 - 19.17 and 2032 - 31.73, highlighting the projected market growth. USD 19.17 Billion USD 31.73 Billion 2024 2032
Diagram Forecast Period
 2025 –2032
Diagram Market Size (Base Year)
 USD 19.17 Billion
Diagram Market Size (Forecast Year)
 USD 31.73 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • Zoetis Services LLC
  • Merck & Co. Inc.
  • Elanco or its affiliates.
  • C.H. Boehringer Ingelheim International GmbH and IDEXX LABORATORIES INC

North America Veterinary Medicine Market, By Type (Therapeutics and Diagnostics), Application (Bacterial Diseases, Canine Atopic Dermatitis, Heminthes Infection, Animal Cancer, Foot and Mouth Disease, Autoimmune Diseases, Bluetongue, and Others), Animal Type (Companion Animals and Production Animal), End User (Veterinary Hospitals, Veterinary Clinics, Animal And Veterinary Farms, Reference Laboratories, Academic And Research Institute, Point-Of-Care Testing/In-House Testing, and Others), Distribution Channel (Retail Sales, Direct Tender, and Others) - Industry Trends & Forecast To 2032

North America Veterinary Medicine Market

North America Veterinary Medicine Market Analysis

The North America veterinary medicine market is expanding rapidly, driven by increasing pet ownership, rising animal health awareness, and advancements in veterinary care. The demand for specialized treatments, vaccines, antibiotics, and anti-inflammatory medications is growing, alongside the need for better disease prevention and management in both companion animals and livestock. Technological advancements, such as biologics and digital diagnostic tools, are further enhancing treatment options. In addition, the increasing prevalence of zoonotic diseases and the focus on preventive care contribute to market growth. With rising spending on pet healthcare and livestock management, the veterinary medicine market is poised for sustained expansion.

North America Veterinary Medicine Market Size

The North America veterinary medicine market is expected to reach USD 31.73 billion by 2032 from USD 19.17 billion in 2024, growing at a CAGR of 6.5% in the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

North America Veterinary Medicine Market Trends

“Increase in Pet Ownership and Advancements”

The North America veterinary medicine market is witnessing significant growth driven by increasing pet ownership, rising animal health awareness, and advancements in veterinary care. The market is shifting toward more specialized treatments for both companion animals and livestock. A growing demand for vaccines, antibiotics, and anti-inflammatory medications is leading to innovations in drug formulations, contributing to better disease prevention and management. The increasing adoption of preventive care practices, such as routine vaccinations and health check-ups, further boosts the market. Moreover, the surge in zoonotic diseases and the need for better disease control in livestock farming are propelling the demand for veterinary medicines.

Report Scope and North America Veterinary Medicine Market Segmentation         

Attributes

North America Veterinary Medicine Market Insights

Segments Covered
  • By Type: Therapeutics and Diagnostics
  • By Application: Bacterial Diseases, Canine Atopic Dermatitis,  Heminthes Infection, Animal Cancer, Foot and Mouth Disease, Autoimmune Diseases, Bluetongue, and Others
  • By Animal Type: Companion Animals and Production Animal
  • By End User: Veterinary Hospitals, Veterinary Clinics, Animal and Veterinary Farm
  • By Reference: Laboratories, Academic and Research Institute, Point-Of-Care Testing/In-House Testing, and Others
  • By Distribution Channel: Retail Sales, Direct Tender, and Others

Region Covered

U.S., Canada, Mexico

Key Market Players
  • Zoetis Services LLC (U.S.), Merck & Co., Inc. (U.S.), Elanco or its affiliates. (U.S.),C.H. Boehringer Ingelheim International GmbH and IDEXX LABORATORIES, INC(Germany), AB Science (France),AdvaCare Pharma (U.S.), ALMAX IMAGING srl (Italy), Anivive (U.S.), BIOMÉRIEUX (France), Bionote USA Inc. (U.S.), Bio-Rad Laboratories (U.S.), Inc., CANON MEDICAL SYSTEMS EUROPE B.V. (Japan), Cargill, Incorporated (U.S.), Ceva (France), CureLab Oncology (U.S.), Dechra Pharmaceuticals Limited (UK), Demeditec Diagnostics GmbH (Germany), DHN International (U.S.), Diagnostic Imaging Systems (U.S.), ESAOTE SPA (Italy), Eurofins Scientific (Luxembourg), Evonik Industries AG (Germany), FUJIFILM Holdings Corporation  (Japan), Gold Standard Diagnostics (U.S.), Hallmarq Veterinary Imaging(UK), Hebei Veyong pharmaceutical Co., Ltd. (China), Heska Corporation (U.S.),IBIS S.R.L. (Italy),Karyopharm (U.S.), Meridian Bioscience, Inc. (U.S.),Narang Medical Limited (India), Neogen Corporation (U.S.), NIPPON ZENYAKU KOGYO CO., LTD. (Japan), Novavive Inc. (U.S.), Nutreco (Netherlands), PLANMECA OY (Finland),RINGPU BIOLOGY Co., Ltd. (China), Shenzhen SONTU Medical Imaging Equipment Co., Ltd (China), Thermo Fisher Scientific Inc. (U.S.), Torigen Pharmaceuticals Inc (U.S.)., VetDC (U.S.), Vetoquinol(France), Virbac(France), VMRD,   Inc. (U.S)

Market Opportunities

  • Growth in Animal Health Biotechnology
  • Increasing Number of Animals Leading to the Demand of Veterinary Medicine
  • Growth in Demand for Nutritional Supplements

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

North America Veterinary Medicine Market Definition

The North America veterinary medicine market encompasses the development, production, and distribution of pharmaceutical products, vaccines, diagnostics, and medical devices aimed at preventing, diagnosing, and treating diseases in animals. It serves both companion animals (such as pets) and livestock (including cattle, poultry, and swine). This market is driven by factors like increasing pet ownership, demand for animal-derived food, heightened awareness of animal health, and technological advancements. It includes products like drugs, vaccines, and parasiticides, with growth fueled by innovations in biotechnology, regulatory standards, and a focus on food safety, quality, and animal welfare worldwide.

North America Veterinary Medicine Market Dynamics

Drivers  

  • Increasing Pet Ownership Boosts Demand for Veterinary Services

The Global veterinary medicine market has experienced significant growth in recent years, driven by an increasing trend in pet ownership and a growing awareness of animal care. As more individuals and families welcome pets into their homes, there is a heightened recognition of the need for professional veterinary services to ensure the health and well-being of these animals. Pet owners are becoming more conscious of the importance of regular veterinary check-ups, preventive care, vaccinations, and early detection of diseases, prompting a surge in demand for veterinary medicines and treatments. In addition, the rise in animal healthcare awareness has led to greater acceptance and adoption of advanced diagnostic tools, therapeutic interventions, and specialized treatments that improve the quality of life for pets. This growing awareness extends beyond traditional pets like dogs and cats, as pet ownership now includes exotic animals, birds, and other species, further diversifying the veterinary medicine market. The increase in disposable income, especially in emerging economies, has allowed more pet owners to afford and prioritize veterinary care, fueling market growth. The expanding pet insurance market also plays a role in driving demand for veterinary medicines, as pet owners seek to protect their pets against unexpected medical expenses. Moreover, the shift towards e-commerce and online veterinary consultations has provided greater accessibility to veterinary products, creating a broader global market for both prescription and over-the-counter veterinary medications. This combination of increased pet ownership, greater awareness of animal health, and advancements in veterinary medicine has created a dynamic and rapidly evolving market, positioning veterinary medicine as a key segment within the broader healthcare industry.

For instance,

  • In September 2021, according to the article published by ReserchGate India's growing pet industry is fueled by increasing awareness of pet care, lifestyle changes, and rising incomes. Pet owners, treating pets as family, invest in health, food, and accessories. Factors like urbanization, pet humanization, and evolving consumer preferences drive this growth, leading to higher pet ownership and awareness.
  • In May  2023, according to the article published by the Times of India  , India's growing awareness of animal welfare is driven by the Prevention of Cruelty to Animals Act, 1960, and initiatives like the Animal Birth Control program. NGOs, such as People for Animals and the Blue Cross of India, actively promote animal protection, rescue efforts, and education, fostering greater pet ownership and care awareness.

In conclusion, the Global veterinary medicine market has experienced substantial growth, largely driven by the increasing trend of pet ownership and a heightened awareness of animal care. As more people adopt pets, they recognize the critical need for professional veterinary services, leading to a surge in demand for veterinary medicines, treatments, and preventive care. This shift towards proactive animal health has also spurred the adoption of advanced diagnostic tools and specialized treatments, benefiting a wider range of pets, including exotic animals and birds. The growing disposable income in emerging economies and the expanding pet insurance market further contribute to this growth, allowing pet owners to prioritize their pets’ healthcare. In addition, the rise of e-commerce and online consultations has improved accessibility to veterinary products, broadening the market for both prescription and over-the-counter medications. Ultimately, the increasing focus on pet health, along with continuous advancements in veterinary medicine, has positioned this sector as a key player in the broader healthcare industry.

  • Rising Animal Diseases Drive Need for Advanced Veterinary Care

The rise in animal diseases, particularly infectious and chronic conditions, has become a significant driver of growth in the Global veterinary medicine market. As diseases like canine parvovirus, feline leukemia, and emerging zoonotic diseases such as avian influenza and swine flu continue to impact both domestic and livestock animals, there is an increased demand for veterinary treatments and preventive measures. The growing prevalence of chronic conditions like arthritis, diabetes, and obesity in pets, alongside a rise in infectious disease outbreaks, has underscored the importance of early detection, vaccination, and continuous management, further driving the need for advanced veterinary care. In addition, the rise in diseases has placed greater emphasis on biosecurity measures, diagnostic testing, and the development of new vaccines and therapeutics, leading to an uptick in veterinary pharmaceutical innovations. As the global animal population increases, particularly in densely populated urban areas, the spread of diseases becomes more likely, necessitating the ongoing development and deployment of veterinary medicines to mitigate health risks. The increasing frequency of disease outbreaks, combined with greater public awareness of the importance of animal health, has spurred investments in research and development, advancing veterinary medicine to address a wide range of animal health challenges. As a result, the demand for veterinary products—ranging from antibiotics and antivirals to vaccines and nutraceuticals—is expected to continue growing, solidifying the veterinary medicine market as a vital segment of the global healthcare industry.

For instance,

  • In June  2022, according to the article published by NCBI, Zoonotic diseases, responsible for millions of human illnesses and deaths annually, pose significant public health risks, as seen with the SARS-CoV-2 pandemic. These diseases impact human, animal, and environmental health, causing economic damage through healthcare costs, lost livestock production, and ecosystem disruption, emphasizing the need for effective prevention strategies.
  • In June 2021, according to the article published by Indian Journal of Medical Research, increased human-animal contact, driven by deforestation, wildlife product demands, and agricultural practices, facilitates the emergence of zoonotic diseases like COVID-19. These outbreaks cause significant health and economic losses. Inadequate public health systems and lack of interdisciplinary approaches highlight the need for comprehensive policies focusing on wildlife protection, land use, and disease prevention.

The rise in animal diseases, both infectious and chronic, is significantly driving growth in the global veterinary medicine market. Conditions like canine parvovirus, feline leukemia, and emerging zoonotic diseases are increasing the demand for veterinary treatments and preventive care. Chronic illnesses such as arthritis and diabetes are also more common, prompting a need for continuous management and early detection. This has led to greater investments in biosecurity, diagnostic testing, vaccines, and therapeutics. As disease outbreaks become more frequent, especially in urban areas, the demand for veterinary medicines continues to rise, making veterinary care a critical segment of global healthcare.

Opportunities

  • Increasing Number Of Animals Leading To The Demand Of Veterinary Medicine

The increasing number of animals, particularly in the livestock sector, provides a significant opportunity for the Global veterinary medicine market. With the rising global population and the corresponding demand for meat, dairy, and other animal products, there is an urgent need for efficient, productive, and healthy livestock. As farmers strive to maximize productivity and ensure animal welfare, the demand for veterinary services and products such as vaccines, antibiotics, and nutritional supplements is set to rise. This growth is further driven by the need to prevent disease outbreaks and ensure food safety, which are critical to maintaining both public health and animal health. Consequently, as the number of livestock animals continues to increase, veterinary medicine will play a crucial role in supporting this industry.

For instance,

  • In March 2021, according to an article published in the Frontiers in Veterinary Science, there are about one billion goats worldwide, and the global goat population has more than doubled during the last four decades. According to the Food and Agriculture Organization, over 90% of goats are found in developing countries; Asia has the largest proportion of the world's goat population, followed by Africa

Moreover, advancements in agricultural practices and the shift towards intensive farming systems are creating additional opportunities within the veterinary medicine market. As farms grow larger and more complex, the health management strategies required to maintain high standards of animal welfare and biosecurity become increasingly sophisticated. This progress opens up avenues for innovative veterinary technologies, including diagnostic tools and health monitoring systems that help farmers identify and mitigate health risks promptly. In addition, the growing emphasis on sustainable farming practices and responsible use of medications is driving the development of more targeted and eco-friendly veterinary products. This alignment of veterinary medicine with evolving agricultural practices generates a fertile ground for growth, innovation, and collaboration among veterinarians, farmers, and pharmaceutical companies.

  • Growth In Animal Health Biotechnology

The growth in animal health biotechnology presents a significant opportunity for the Global veterinary medicine market by facilitating the development of innovative and targeted solutions for animal health management. Advancements in biotechnology, such as genetic engineering, gene therapy, and immunology, enable the creation of vaccines tailored to specific diseases, improving their efficacy and safety. This shift towards biotechnological approaches addresses the increasing concerns over antibiotic resistance in livestock, as biotechnology can lead to the development of alternatives to traditional antibiotics, thereby ensuring healthier animals and enhancing food safety. As consumers demand safer and higher-quality animal products, the application of biotechnology in veterinary medicine can meet these expectations while facilitating more sustainable agricultural practices.

For instance,

  • In September 2023, according to an article published by ResearchGate, Animal biotechnology represents a cutting-edge field that has revolutionized our interactions with the animal kingdom. Recent advancements encompass various domains, including genetic editing techniques like CRISPR-Cas9, which allow precise genetic modifications for improved animal health and product quality.
  • In August 2024, according to an article published by the National Institute of Food and Agriculture, Advances in animal biotechnology have been facilitated by recent progress in sequencing animal genomes, gene expression and metabolic profiling of animal cells. More recently, genome editing technologies (Zinc Finger Nucleases, TALENS, and CRISPR-Cas systems) have opened up new opportunities to easily create genetic variations in animals that can improve their health and well-being, agricultural production, and protection against diseases.

In addition, the integration of biotechnology into animal health fosters improved diagnostics and treatments that can enhance animal welfare and productivity. Tools derived from biotechnological advancements, such as molecular diagnostics and biomarker identification, allow for more precise disease detection and monitoring, enabling veterinarians to implement timely interventions. This not only benefits the health of the animals but also reduces economic losses for farmers due to disease outbreaks and suboptimal productivity. The growing emphasis on precision veterinary medicine—leveraging data to tailor interventions—further amplifies the demand for biotechnological innovations. As a result, stakeholders in the Global Veterinary Medicine Market—including pharmaceutical companies, researchers, and technology developers—stand to gain significantly as they invest in and harness the potential of animal health biotechnology to improve outcomes for both animals and the agricultural sector as a whole.

Restraints/Challenges

  • High Veterinary Care Costs Limit Market Accessibility

 The high cost of veterinary care represents a significant restraint on market accessibility, directly impacting both pet owners and livestock producers globally. For pet owners, the expense associated with advanced diagnostics, surgeries, and specialty care often leads to difficult healthcare decisions, with many opting for cost-effective solutions or delaying necessary treatments for their animals. This has driven a growing demand for affordable alternatives such as over-the-counter medications, preventive care treatments, and vaccines. In addition, pet insurance has become a more popular option to offset the financial burden of veterinary services. In parallel, livestock producers, particularly in developing economies, face financial constraints that hinder their ability to access the full spectrum of veterinary care required to maintain optimal animal health. This limitation affects the quality of care they can provide to their animals, leading to an increased need for more cost-efficient solutions like generic medications, nutraceuticals, and vaccines for disease prevention. The high costs also spur innovation within the veterinary industry as companies seek to develop affordable treatments that do not sacrifice quality. Furthermore, as veterinary care becomes more specialized and reliant on advanced technologies, the focus is shifting toward streamlining services and implementing preventive care models. These models aim to reduce long-term costs for both pet owners and agricultural producers, emphasizing the importance of cost efficiency in shaping the evolution of the veterinary medicine market. Despite these efforts, the high cost of veterinary services remains a major barrier, limiting accessibility and influencing the growth trajectory of the market.

For instance,

  • In July 2024, according to the article published by NCBI, veterinary procedure costs, such as dog and cat GDY, saw significant increases between autumn 2022 and winter 2023/2024, with prices rising by 2–24%. Emergency surgeries and equine GDY also experienced sharp cost hikes, highlighting the financial burden of veterinary care, with substantial price variations across countries and procedures.
  • In July 2020, according to the article published by NCBI, despite the growing popularity of dog ownership, veterinary visits have declined, while the average cost per visit has risen from USD 138 to USD 161. Increased labor costs, medical supplies, and equipment contribute to the higher expenses. Pet health insurance also raises veterinary spending, impacting pet owners’ overall care costs.

In conclusion, the high cost of veterinary care is a significant driver in the global veterinary medicine market, influencing both pet owners and livestock producers to seek more affordable and accessible solutions. This has led to a rising demand for cost-effective products such as vaccines, preventive treatments, and generics. In addition, the high costs are encouraging innovation within the industry, with a focus on developing affordable, quality treatments and streamlining services. As both pet and livestock owners seek to manage expenses, the demand for economical veterinary care options will continue to shape the growth and evolution of the veterinary medicine market.

  • Challenges Of Regulatory Compliance And Complexity

Regulatory and compliance issues are significant challenges in the Global veterinary medicine market due to the complex, region-specific requirements that companies must navigate to ensure their products meet safety standards and are approved for use. Different countries and regions have varying regulatory bodies, each with its own set of guidelines for the approval of veterinary medicines. For instance, in the U.S., the Food and Drug Administration (FDA) is responsible for ensuring the safety and efficacy of veterinary products, while in the European Union, the European Medicines Agency (EMA) regulates these products. These regulatory bodies often have rigorous and time-consuming approval processes, including extensive testing, documentation, and periodic reviews, which can delay the launch of new veterinary medicines.

Moreover, the increasing focus on animal welfare and environmental safety has introduced additional layers of complexity. Compliance with these regulations often requires manufacturers to conduct more comprehensive research, including animal testing and long-term safety assessments, which can be costly and time-consuming. In certain countries, regulations may be stricter or less transparent, creating uncertainties and slowing down market entry. Companies must also adapt their products to meet different regulatory frameworks for different markets, which can further complicate product distribution and increase operational costs.

For instance,

  • In July 2024, according to an news published by Rebexa Group, Navigating diverse regulatory requirements across regions creates significant challenges for the global veterinary medicine market. Varying approval processes, safety standards, and animal welfare regulations increase costs and delay product launches. Emerging concerns, like antimicrobial resistance, lead to evolving guidelines, further complicating compliance and hindering the market's growth potential.
  • In July 2021, according to an article published by ScienceDriect the complexities of global veterinary medicine regulations, noting that each country, such as the USA, EU, and Australia, has different approval processes and safety standards. The absence of unified frameworks for zoonotic diseases, veterinary drug stockpiling, and pharmacovigilance centers in many nations adds to the challenge, hindering market development and consistency in veterinary care globally.

Regulatory and compliance challenges create significant barriers to entry, delay product availability, and increase costs for companies in the veterinary medicine market. Addressing these obstacles through streamlined processes and international regulatory harmonization could alleviate some of the pressure, enabling faster market access, better alignment with animal health needs, and ultimately improved animal welfare worldwide.

North America Veterinary Medicine Market Scope

North America veterinary medicine market is segmented into five notable segments based on type, application, animal type, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Therapeutics
    • Pharmaceuticals
      • Antibiotics
        • Tetracycline
        • Penicillins
        • Macrolides
        • Aminoglycosides
        • Lincosamides
        • Colistin
        • Others
      • Parasiticides
        • Benzimidazoles
        • Macrocyclic Lactones
        • Pyrethroids
        • Amprolium
        • Nitroimidazoles
        • Piperazine
        • Others
      • Anlagesics/Anti-Inflammatory (Nsaids)
        • Carprofen
        • Meloxicam
        • Phenylbutazone
        • Acetaminophen
        • Firocoxib
        • Deracoxib
        • Others
      • Antihistamines
        • Cetirizine
        • Brompheniramine
        • Diphenhydramine
        • Terfenadine
        • Trimeprazine
        • Others
      • Corticosteroids
        • Dexamethasone
        •  Prednisolone
        •  Prednisone
        •  Others
      • Antibloat
        • Docusate
        • Simethicone
        • Others
      • Hormonal
        • Equine Chorionic Gonadotropin
        • Cloprostenol
        • Oxytocin
        • Others
    • Opioids
      • Mu Agonists
        • Methadone
        •  Meperidine
        •  Morphine
        •  Oxymorphone
        •  Others
      • Partial Mu Agonist
        • Buprenorphine
        • Others
      • Kappa Agonist-Mu Anatgonist
        • Butorphanol
        • Others
    • Others
    • Branded
    • Generic
    • Prescription Based
    • Over The Counter
    • Oral
      • Tablets
      • Solutions
      • Powder
      • Others
    • Parental
      • Intraveneous
      • Subcutaneous
      • Others
    • Topical
    • Others
  • Vaccines
    • Live Attenuated Vaccines
    • Toxoid Vaccines
    • Recombinant Vaccines
    • Inactivated Vaccines
    • Others
  • Biologics
    • Marketed
      • Toceranib
      • Lomustine
      • Cyclophosphamide
      • Chlorambucil
      • Others
    • Emerging
  • Medicated Feed Additives
    • Enzymes
      • Phytase
      • Carbohydrase
      • Protease
      • Amylase
      • Cellulase
      • Mannase
      • Glucanase
      • Xylanase
      • Others
  • Amino Acid
    • Lysine
    • Methionine
    • Threonine
    • Tryptophan
    • Others
  • Vitamins
    • Fat-Soluble Vitamin
      • Vitamin A
      • Vitamin E
      • Vitamin D
      • Vitamin K
    • Water-Soluble Vitamin
      • Vitamin B Complex
      • Vitamin C
  • Antioxidants
    • Bha
    • Bht
    • Ethoxyquin
    • Others
  • Probiotics
    • Lactobacilli
    • Bifidobacteria
    • Yeast
    • Stretococcus Thermophilus
  • Feed Acidifiers
    • Propionic Acid
    • Formic Acid
    • Lactic Acid
    • Citric Acid
    • Others
  • Mycotoxin Detoxifiers
    • Mycotoxin Binders
      • Silicates
      • Clays
      • Chemical Polymers
      • Glucan Products
      • Others
    • Mycotoxin Modifiers
  • Phytogenic
    • Essential Oils
    • Herbs & Spices
    • Oleoresin
    • Others
  • Carotenoids
    • Beta-Carotene
    • Astaxanthin
    • Lutein
    • Canthaxanthin
  • Trace Minerals
    • Zinc
    • Copper
    • Manganese
    • Iron
    • Selenium
    • Others
  • Preservatives
    • Anticaking Agents
    • Mold Inhibitors
  • Flavours And Sweeteners
    • Flavours
    • Sweeteners
      • Saccharin
      • Neohesperidin Dihydrochalcone
      • Glycyrrhizin
      • Thaumatin
      • Others
    • Others
  • Diagnostics
    • Instruments & Devices
      • Imaging Devices
        • X-Ray Imaging (Radiography)
          • Small Animals
          • Large Animals
        • Ultrasound
          • Small Animals
          • Large Animals
        • Computed Tomography
          • Small Animals
          • Large Animals
        • Magnetic Resonance Imaging
          • Small Animals
          • Large Animals
        • Single-Photon Emission Computed Tomography (Spect)
          • Small Animals
          • Large Animals
        • Others
  • Laboratory Instruments
    • Hematology Analyzers
      • Automatic
      • Semi-Automatic
      • High Price Range
      • Standard Price Range
      • Benchtop
      • Portable
      • Others
    • Chemistry Analyzers
      • Automatic
      • Semi-Automatic
      • Benchtop
      • Portable
      • Blood
      • Urine
      • Stool
      • Others
    • Point-Of-Care Instruments
      • Lateral Flow Poct
      • Molecular Poct
      • Others
    • Coagulation Analyzers
      • Automatic
      • Semi-Automatic
      • 4-Channel
      • 1-Channel
      • Whole Blood
      • Plasma
      • Benchtop
      • Portable
    • Urinalysis Equipment
      • Automatic
      • Semi-Automatic
    • Refractometer
      • Optical
      • Digital
      • Benchtop
      • Portable
    • Others
  • Reagents & Consumables
    • Kits
      • Pcr Kits
      • Rapid Test Kits
      • Multiplex Kits
      • Elisa Kits
      • Sample Preparation Kits Isolation And Extraction Kits
      • Others
    • Reagents
      • Nucleic Acid Extraction Reagents
      • Immunofluorescence Reagents
      • Coombs Reagents
      • Others Reagents
  • Media
  • Panel
  • Strips
  • Cassette
  • Control Standards
  • Probes And Primer
  • Others Consumable And Accessories

Application

  • Bacterial Diseases
    • Production Animals
    • Companion Animals
  • Canine Atopic Dermatitis
    • Companion Animals
    • Production Animals
  • Heminthes Infection
    • Production Animals
    • Companion Animals
  • Animal Cancer
    • Companion Animals
    • Production Animals
  • Foot And Mouth Disease
    • Production Animals
    • Companion Animals
  • Autoimmune Diseases
    • Companion Animals
    • Production Animals
  • Bluetongue
    • Production Animals
    • Companion Animals
  • Others
    • Companion Animals
    • Production Animal

Animal Type

  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Others
  • Production Animal
    • Poultry
    • Cattle
    • Swine
    • Fish
    • Sheep & Goats
    • Others

End User

  • Veterinary Hospitals
    • Private
    • Public
    • Tier 2
    • Tier 1
    • Tier 3
  • Veterinary Clinics
    • Public
    • Private
  • Animal And Veterinary Farms
  • Reference Laboratories
  • Academic And Research Institute
  • Point-Of-Care Testing/In-House Testing
  • Others

Distribution Channel

  • Retail Sales
    • Offline
      • Hospital Pharmacy
      • Retail Pharmacy
    • Online
      • E-Commerce Platforms
      • Company Website
      • Others
  • Direct Tender
  • Others

North America Veterinary Medicine Market Regional Analysis

The market is analyzed and market size insights and trends are provided based on country, type, application, animal type, end user, and distribution channel as referenced above.

The countries covered in the market are U.S., Canada, Mexico.

U.S. is expected to dominate the North America veterinary medicine market due to technological advancements, strategic investments, and expanding pharmaceutical exports. Its competitive pricing and innovation in animal healthcare solutions are helping it gain a strong foothold, challenging local players and reshaping the region's veterinary landscape.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

North America Veterinary Medicine Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

North America Veterinary Medicine Market Leaders Operating in the Market Are:

  • Zoetis Services LLC (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Elanco or its affiliates (U.S.)
  • C.H. Boehringer Ingelheim International GmbH (Germany)
  • IDEXX LABORATORIES, INC (Germany)
  • AB Science (France)
  • AdvaCare Pharma (U.S.)
  • ALMAX IMAGING srl (Italy)
  • Anivive (U.S.)
  • BIOMÉRIEUX (France)
  • Bionote USA Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • CANON MEDICAL SYSTEMS EUROPE B.V. (Japan)
  • Cargill, Incorporated (U.S.)
  • Ceva (France)
  • CureLab Oncology (U.S.)
  • Dechra Pharmaceuticals Limited (UK)
  • Demeditec Diagnostics GmbH (Germany)
  • DHN International (U.S.)
  • Diagnostic Imaging Systems (U.S.)
  • ESAOTE SPA (Italy)
  • Eurofins Scientific (Luxembourg)
  • Evonik Industries AG (Germany)
  • FUJIFILM Holdings Corporation (Japan)
  • Gold Standard Diagnostics (U.S.)
  • Hallmarq Veterinary Imaging (UK)
  • Hebei Veyong Pharmaceutical Co., Ltd. (China)
  • Heska Corporation (U.S.)
  • IBIS S.R.L. (Italy)
  • Karyopharm (U.S.)
  • Meridian Bioscience, Inc. (U.S.)
  • Narang Medical Limited (India)
  • Neogen Corporation (U.S.)
  • NIPPON ZENYAKU KOGYO CO., LTD. (Japan)
  • Novavive Inc. (U.S.)
  • Nutreco (Netherlands)
  • PLANMECA OY (Finland)
  • RINGPU BIOLOGY Co., Ltd. (China)
  • Shenzhen SONTU Medical Imaging Equipment Co., Ltd (China)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Torigen Pharmaceuticals Inc. (U.S.)
  • VetDC (U.S.)
  • Vetoquinol (France)
  • Virbac (France)
  • VMRD, Inc. (U.S.)

Latest Developments North America Veterinary Medicine Market

  • In February 2023 , Vetoquinol introduces Lygoferrin, a scientifically formulated, natural immunity booster designed to strengthen defense mechanisms in animals. This innovative product enhances resistance against infections by supporting the body's innate immune response. Lygoferrin helps reduce dependency on antibiotics, promoting overall health and well-being in livestock and companion animals. Its advanced formula ensures rapid absorption and effective protection, minimizing the risk of bacterial and viral infections. With this launch, Vetoquinol reinforces its commitment to sustainable animal health solutions, providing veterinarians and farmers with a reliable, natural alternative to enhance immunity and improve productivity in animal care
  • In February 2023, Vetoquinol introduces Immun-C Aqua, an advanced water-soluble immune booster designed to enhance the health and resilience of aquatic species. This innovative formula strengthens disease resistance, improves overall vitality, and optimizes growth performance in fish and shrimp farming. By fortifying the immune system, Immun-C Aqua helps reduce mortality rates and enhances survival in challenging environments. With a scientifically developed composition, it ensures rapid absorption and effective action, contributing to sustainable and productive aquaculture. This launch underscores Vetoquinol’s commitment to providing high-quality, research-backed solutions for the aquaculture industry, supporting healthier aquatic livestock and improving farm profitability
  • In January 2025 , Laurie Hueneke Martens, Associate VP of North America Public Policy and Government Relations at Merck Animal Health, received the 8th Annual Feather in Her Cap Award. Recognized for her leadership in public policy and mentoring future women leaders, Hueneke also saw a USD 5,000 donation made to her chosen animal charities
  • In February 2024, Merck Animal Health announced that the European Commission has granted marketing authorization for BRAVECTO TriUNO, a new chewable tablet for dogs. This product targets both internal and external parasites, offering protection against fleas, ticks, gastrointestinal nematodes, heartworm, and angiostrongylosis. It is now approved in multiple countries, including Peru and Costa Rica
  • In November 2024, Merck Animal Health announced the winners of the 2024 High-Quality Pork Pignnovation Award. Romain Delcombel of BioAZ won Champion, with Joao Lopes of Redsoft Technologica LTDA as Runner-Up and Jaap de Wit of Westfort in third. The awards recognize their innovative contributions to swine industry advancements in health, welfare, and sustainability

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE NORTH AMERICA VETERINARY MEDICINE MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 DBMR MARKET POSITION GRID

2.8 MARKET END USER COVERAGE GRID

2.9 VENDOR SHARE ANALYSIS

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

4.3 PIPELINE ANALYSIS

4.4 TOP ENTITIES BASED ON R&D GLANCE FOR VETERINARY MEDICINE MARKET

4.5 EPIDEMIOLOGY

5 NORTH AMERICA VETERINARY MEDICINE MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PET OWNERSHIP BOOSTS DEMAND FOR VETERINARY SERVICES

6.1.2 RISING ANIMAL DISEASES DRIVE NEED FOR ADVANCED VETERINARY CARE

6.1.3 VETERINARY MEDICINE ADVANCES IMPROVE DIAGNOSIS AND TREATMENT OPTIONS

6.1.4 RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS INCREASES VETERINARY NEEDS

6.2 RESTRAINTS

6.2.1 HIGH VETERINARY CARE COSTS LIMIT MARKET ACCESSIBILITY

6.2.2 LACK OF AWARENESS ABOUT ANIMAL HEALTH LIMITS PROPER VETERINARY CARE ACCESS

6.3 OPPORTUNITIES

6.3.1 INCREASING NUMBER OF ANIMALS LEADING TO THE DEMAND OF VETERINARY MEDICINE

6.3.2 GROWTH IN ANIMAL HEALTH BIOTECHNOLOGY

6.3.3 GROWTH IN DEMAND FOR NUTRITIONAL SUPPLEMENTS

6.4 CHALLENGES

6.4.1 CHALLENGES OF REGULATORY COMPLIANCE AND COMPLEXITY

6.4.2 SHORTAGE OF VETERINARY PROFESSIONALS

7 NORTH AMERICA VETERINARY MEDICINE MARKET, BY TYPE

7.1 OVERVIEW

7.2 THERAPEUTICS

7.2.1 PHARMACEUTICALS

7.2.1.1 ANTIBIOTICS

7.2.1.1.1 TETRACYCLINE

7.2.1.1.2 PENICILLINS

7.2.1.1.3 MACROLIDES

7.2.1.1.4 AMINOGLYCOSIDES

7.2.1.1.5 LINCOSAMIDES

7.2.1.1.6 COLISTIN

7.2.1.1.7 OTHERS

7.2.1.2 PARASITICIDES

7.2.1.2.1 BENZIMIDAZOLES

7.2.1.2.2 MACROCYCLIC LACTONES

7.2.1.2.3 PYRETHROIDS

7.2.1.2.4 AMPROLIUM

7.2.1.2.5 NITROIMIDAZOLES

7.2.1.2.6 PIPERAZINE

7.2.1.2.7 OTHERS

7.2.1.3 ANALGESICS/ANTI-INFLAMMATORY (NSAIDS)

7.2.1.3.1 CARPROFEN

7.2.1.3.2 MELOXICAM

7.2.1.3.3 PHENYLBUTAZONE

7.2.1.3.4 ACETAMINOPHEN

7.2.1.3.5 FIROCOXIB

7.2.1.3.6 DERACOXIB

7.2.1.3.7 OTHERS

7.2.1.4 ANTIHISTAMINES

7.2.1.4.1 CETIRIZINE

7.2.1.4.2 BROMPHENIRAMINE

7.2.1.4.3 DIPHENHYDRAMINE

7.2.1.4.4 TERFENADINE

7.2.1.4.5 TRIMEPRAZINE

7.2.1.4.6 OTHERS

7.2.1.5 CORTICOSTEROIDS

7.2.1.5.1 DEXAMETHASONE

7.2.1.5.2 PREDNISOLONE

7.2.1.5.3 PREDNISONE

7.2.1.5.4 OTHERS

7.2.1.6 ANTIBLOAT

7.2.1.6.1 DOCUSATE

7.2.1.6.2 SIMETHICONE

7.2.1.6.3 OTHERS

7.2.1.7 HORMONAL

7.2.1.7.1 EQUINE CHORIONIC GONADOTROPIN

7.2.1.7.2 CLOPROSTENOL

7.2.1.7.3 OXYTOCIN

7.2.1.7.4 OTHERS

7.2.1.8 OPIOIDS

7.2.1.8.1 MU AGONISTS

7.2.1.8.1.1 METHADONE

7.2.1.8.1.2 MEPERIDINE

7.2.1.8.1.3 MORPHINE

7.2.1.8.1.4 OXYMORPHONE

7.2.1.8.1.5 OTHERS

7.2.1.8.2 PARTIAL MU AGONIST

7.2.1.8.2.1 BUPRENORPHINE

7.2.1.8.2.2 OTHERS

7.2.1.8.3 KAPPA AGONIST-MU ANTAGONIST

7.2.1.8.3.1 BUTORPHANOL

7.2.1.8.3.2 OTHERS

7.2.1.9 OTHERS

7.2.1.10 PHARMACEUTICALS BY DRUG TYPE

7.2.1.10.1 BRANDED

7.2.1.10.2 GENERIC

7.2.1.11 PHARMACEUTICALS BY PRESCRIPTION MODE

7.2.1.11.1 PRESCRIPTION BASED

7.2.1.11.2 OVER THE COUNTER

7.2.1.12 PHARMACEUTICALS BY ROUTE OF ADMINISTRATION,

7.2.1.12.1 ORAL

7.2.1.12.1.1 TABLETS

7.2.1.12.1.2 SOLUTIONS

7.2.1.12.1.3 POWDER

7.2.1.12.1.4 OTHERS

7.2.1.12.2 PARENTAL

7.2.1.12.2.1 INTRAVENOUS

7.2.1.12.2.2 SUBCUTANEOUS

7.2.1.12.2.3 OTHERS

7.2.1.12.3 TOPICAL

7.2.1.12.4 OTHERS

7.2.2 VACCINES

7.2.2.1 LIVE ATTENUATED VACCINES

7.2.2.2 TOXOID VACCINES

7.2.2.3 RECOMBINANT VACCINES

7.2.2.4 INACTIVATED VACCINES

7.2.2.5 OTHERS

7.2.3 BIOLOGICS

7.2.3.1 MARKETED

7.2.3.1.1 TOCERANIB

7.2.3.1.2 LOMUSTINE

7.2.3.1.3 CYCLOPHOSPHAMIDE

7.2.3.1.4 CHLORAMBUCIL

7.2.3.1.5 OTHERS

7.2.3.2 EMERGING

7.2.4 MEDICATED FEED ADDITIVES

7.2.4.1 ENZYMES

7.2.4.1.1 PHYTASE

7.2.4.1.2 CARBOHYDRASE

7.2.4.1.3 PROTEASE

7.2.4.1.4 AMYLASE

7.2.4.1.5 CELLULASE

7.2.4.1.6 MANNASE

7.2.4.1.7 GLUCANASE

7.2.4.1.8 XYLANASE

7.2.4.1.9 OTHERS

7.2.4.2 AMINO ACID

7.2.4.2.1 LYSINE

7.2.4.2.2 METHIONINE

7.2.4.2.3 THREONINE

7.2.4.2.4 TRYPTOPHAN

7.2.4.2.5 OTHERS

7.2.4.3 VITAMINS

7.2.4.3.1 FAT-SOLUBLE VITAMIN

7.2.4.3.1.1 VITAMIN A

7.2.4.3.1.2 VITAMIN E

7.2.4.3.1.3 VITAMIN D

7.2.4.3.1.4 VITAMIN K

7.2.4.3.2 WATER-SOLUBLE VITAMIN

7.2.4.3.2.1 VITAMIN B COMPLEX

7.2.4.3.2.2 VITAMIN C

7.2.4.4 ANTIOXIDANTS

7.2.4.4.1 BHA

7.2.4.4.2 BHT

7.2.4.4.3 ETHOXYQUIN

7.2.4.4.4 OTHERS

7.2.4.5 PROBIOTICS

7.2.4.6 LACTOBACILLI

7.2.4.7 BIFIDOBACTERIA

7.2.4.8 YEAST

7.2.4.9 STRETOCOCCUS THERMOPHILUS

7.2.4.10 FEED ACIDIFIERS

7.2.4.10.1 PROPIONIC ACID

7.2.4.10.2 FORMIC ACID

7.2.4.10.3 LACTIC ACID

7.2.4.10.4 CITRIC ACID

7.2.4.10.5 OTHERS

7.2.4.11 MYCOTOXIN DETOXIFIERS

7.2.4.11.1 MYCOTOXIN BINDERS

7.2.4.11.1.1 SILICATES

7.2.4.11.1.2 CLAYS

7.2.4.11.1.3 CHEMICAL POLYMERS

7.2.4.11.1.4 GLUCAN PRODUCTS

7.2.4.11.1.5 OTHERS

7.2.4.11.2 MYCOTOXIN MODIFIERS

7.2.4.12 PHYTOGENIC

7.2.4.12.1 ESSENTIAL OILS

7.2.4.12.2 HERBS & SPICES

7.2.4.12.3 OLEORESIN

7.2.4.12.4 OTHERS

7.2.4.13 CAROTENOIDS

7.2.4.13.1 BETA-CAROTENE

7.2.4.13.2 ASTAXANTHIN

7.2.4.13.3 LUTEIN

7.2.4.13.4 CANTHAXANTHIN

7.2.4.14 TRACE MINERALS

7.2.4.14.1 ZINC

7.2.4.14.2 COPPER

7.2.4.14.3 MANGANESE

7.2.4.14.4 IRON

7.2.4.14.5 SELENIUM

7.2.4.14.6 OTHERS

7.2.4.15 PRESERVATIVES

7.2.4.15.1 ANTICAKING AGENTS

7.2.4.15.2 MOLD INHIBITORS

7.2.4.16 FLAVOURS AND SWEETENERS

7.2.4.16.1 FLAVORS

7.2.4.16.2 SWEETENERS

7.2.4.16.2.1 SACCHARIN

7.2.4.16.2.2 NEOHESPERIDIN DIHYDROCHALCONE

7.2.4.16.2.3 GLYCYRRHIZIN

7.2.4.16.2.4 THAUMATIN

7.2.4.16.2.5 OTHERS

7.2.4.17 OTHERS

7.3 DIAGNOSTICS

7.3.1 INSTRUMENTS & DEVICES

7.3.1.1 IMAGING DEVICES

7.3.1.2 X-RAY IMAGING (RADIOGRAPHY)

7.3.1.2.1 SMALL ANIMALS

7.3.1.2.2 LARGE ANIMALS

7.3.1.3 ULTRASOUND

7.3.1.3.1 SMALL ANIMALS

7.3.1.3.2 LARGE ANIMALS

7.3.1.4 COMPUTED TOMOGRAPHY

7.3.1.4.1 SMALL ANIMALS

7.3.1.4.2 LARGE ANIMALS

7.3.1.5 MAGNETIC RESONANCE IMAGING

7.3.1.5.1 SMALL ANIMALS

7.3.1.5.2 LARGE ANIMALS

7.3.1.6 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)

7.3.1.6.1 SMALL ANIMALS

7.3.1.6.2 LARGE ANIMALS

7.3.1.6.3 OTHERS

7.3.2 LABORATORY INSTRUMENTS

7.3.2.1 HEMATOLOGY ANALYZERS

7.3.2.1.1 BY MODE

7.3.2.1.1.1 AUTOMATIC

7.3.2.1.1.2 SEMI-AUTOMATIC

7.3.2.1.2 BY PRICE RANGE

7.3.2.1.2.1 HIGH PRICE RANGE

7.3.2.1.2.2 STANDARD PRICE RANGE

7.3.2.1.3 BY MODALITY,

7.3.2.1.3.1 BENCHTOP

7.3.2.1.3.2 PORTABLE

7.3.2.1.3.3 OTHERS

7.3.2.2 CHEMISTRY ANALYZERS

7.3.2.2.1 BY MODE

7.3.2.2.1.1 AUTOMATIC

7.3.2.2.1.2 SEMI-AUTOMATIC

7.3.2.2.2 BY MODALITY,

7.3.2.2.2.1 BENCHTOP

7.3.2.2.2.2 PORTABLE

7.3.2.2.3 BY SAMPLE TYPE,

7.3.2.2.3.1 BLOOD

7.3.2.2.3.2 URINE

7.3.2.2.3.3 STOOL

7.3.2.2.3.4 OTHERS

7.3.2.3 POINT-OF-CARE INSTRUMENTS

7.3.2.3.1 BY TYPE

7.3.2.3.1.1 LATERAL FLOW POCT

7.3.2.3.1.2 MOLECULAR POCT

7.3.2.3.1.3 OTHERS

7.3.2.3.2 BY MODE

7.3.2.3.2.1 AUTOMATIC

7.3.2.3.2.2 SEMI-AUTOMATIC

7.3.2.4 COAGULATION ANALYZERS

7.3.2.4.1 BY CHANNEL,

7.3.2.4.1.1.1 4-CHANNEL

7.3.2.4.1.1.2 1-CHANNEL

7.3.2.4.2 BY SAMPLE TYPE

7.3.2.4.2.1 WHOLE BLOOD

7.3.2.4.2.2 PLASMA

7.3.2.4.3 BY MODALITY,

7.3.2.4.3.1 BENCHTOP

7.3.2.4.3.2 PORTABLE

7.3.2.5 URINALYSIS EQUIPMENT

7.3.2.5.1 BY MODE

7.3.2.5.1.1 AUTOMATIC

7.3.2.5.1.2 SEMI-AUTOMATIC

7.3.2.6 REFRACTOMETER

7.3.2.6.1 BY MODE,

7.3.2.6.1.1 OPTICAL

7.3.2.6.1.2 DIGITAL

7.3.2.6.2 BY MODALITY,

7.3.2.6.2.1 BENCHTOP

7.3.2.6.2.2 PORTABLE

7.3.2.7 OTHERS

7.3.3 REAGENTS & CONSUMABLES

7.3.3.1 KITS

7.3.3.1.1 PCR KITS

7.3.3.1.2 RAPID TEST KITS

7.3.3.1.3 MULTIPLEX KITS

7.3.3.1.4 ELISA KITS

7.3.3.1.5 SAMPLE PREPARATION KITS ISOLATION AND EXTRACTION KITS

7.3.3.1.6 OTHERS

7.3.3.2 REAGENTS

7.3.3.2.1 NUCLEIC ACID EXTRACTION REAGENTS

7.3.3.2.2 IMMUNOFLUORESCENCE REAGENTS

7.3.3.2.3 COOMBS REAGENTS

7.3.3.2.4 OTHERS REAGENTS

7.3.4 MEDIA

7.3.5 PANEL

7.3.6 STRIPS

7.3.7 CASSETTE

7.3.8 CONTROL STANDARDS

7.3.9 PROBES AND PRIMER

7.3.10 OTHERS CONSUMABLE AND ACCESSORIES

8 NORTH AMERICA VETERINARY MEDICINE MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 BACTERIAL DISEASES

8.2.1 PRODUCTION ANIMALS

8.2.2 COMPANION ANIMALS

8.3 CANINE ATOPIC DERMATITIS

8.3.1 COMPANION ANIMALS

8.3.2 PRODUCTION ANIMALS

8.4 HEMINTHES INFECTION

8.4.1 PRODUCTION ANIMALS

8.4.2 COMPANION ANIMALS

8.5 ANIMAL CANCER

8.5.1 COMPANION ANIMALS

8.5.2 PRODUCTION ANIMALS

8.6 FOOT AND MOUTH DISEASE

8.6.1 PRODUCTION ANIMALS

8.6.2 COMPANION ANIMALS

8.7 AUTOIMMUNE DISEASES

8.7.1 COMPANION ANIMALS

8.7.2 PRODUCTION ANIMALS

8.8 BLUETONGUE

8.8.1 PRODUCTION ANIMALS

8.8.2 COMPANION ANIMALS

8.9 OTHERS

8.9.1 COMPANION ANIMALS

8.9.2 PRODUCTION ANIMAL

9 NORTH AMERICA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE

9.1 OVERVIEW

9.2 COMPANION ANIMALS

9.2.1 DOGS

9.2.2 CATS

9.2.3 HORSES

9.2.4 OTHERS

9.3 PRODUCTION ANIMAL

9.3.1 POULTRY

9.3.2 CATTLE

9.3.3 SWINE

9.3.4 FISH

9.3.5 SHEEP & GOATS

9.3.6 OTHERS

10 NORTH AMERICA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 RETAIL SALES

10.2.1 OFFLINE

10.2.1.1 HOSPITAL PHARMACY

10.2.1.2 RETAIL PHARMACY

10.2.2 ONLINE

10.2.2.1 E-COMMERCE PLATFORMS

10.2.2.2 COMPANY WEBSITE

10.2.2.3 OTHERS

10.3 DIRECT TENDER

10.4 OTHERS

11 NORTH AMERICA VETERINARY MEDICINE MARKET, BY END USER

11.1 OVERVIEW

11.2 VETERINARY HOSPITALS

11.2.1 PRIVATE

11.2.2 PUBLIC

11.2.3 VETERINARY HOSPITALS BY LEVEL

11.2.3.1 TIER 2

11.2.3.2 TIER 1

11.2.3.3 TIER 3

11.3 VETERINARY CLINICS

11.3.1 VETERINARY CLINICS BY TYPE

11.3.1.1 PUBLIC

11.3.1.2 PRIVATE

11.4 ANIMAL AND VETERINARY FARMS

11.5 REFERENCE LABORATORIES

11.6 ACADEMIC AND RESEARCH INSTITUTE

11.7 POINT-OF-CARE TESTING/IN-HOUSE TESTING

11.8 OTHERS

12 NORTH AMERICA VETERINARY MEDICINE MARKET, BY REGION

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

13 NORTH AMERICA VETERINARY MEDICINE MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: GLOBAL

14 SWOT ANALYSIS

15 COMPANY PROFILES

15.1 ZOETIS SERVICES LLC SERVICES LLC.

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENT

15.2 MERCK KGAA

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENT

15.3 ELANCO OR ITS AFFILIATES. OR ITS AFFILIATES

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENT

15.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH

15.4.1 COMPANY SNAPSHOT

15.4.2 COMPANY SHARE ANALYSIS

15.4.3 PRODUCT PORTFOLIO

15.4.4 RECENT DEVELOPMENT

15.5 IDEXX LABORATORIES, INC

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENT

15.6 AB SCIENCE

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENT

15.7 ADVACARE PHARMA

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 RECENT DEVELOPMENT

15.8 ALMAX IMAGING SRL

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 ANIVIVE

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.1 BIOMÉRIEUX

15.10.1 COMPANY SNAPSHOT

15.10.2 REVENUE ANALYSIS

15.10.3 PRODUCT PORTFOLIO

15.10.4 RECENT DEVELOPMENT

15.11 BIONOTE USA INC.

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENT

15.12 BIO-RAD LABORATORIES, INC.

15.12.1 COMPANY SNAPSHOT

15.12.2 REVENUE ANALYSIS

15.12.3 PRODUCT PORTFOLIO

15.12.4 RECENT DEVELOPMENT

15.13 CANON MEDICAL SYSTEMS EUROPE B.V.

15.13.1 COMPANY SNAPSHOT

15.13.2 REVENUE ANALYSIS

15.13.3 PRODUCT PORTFOLIO

15.13.4 RECENT DEVELOPMENT

15.14 CARGIL INCORPORATED

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 CEVA

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 CURELAB ONCOLOGY

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENT

15.17 DECHRA PHARMACEUTICALS LIMITED

15.17.1 COMPANY SNAPSHOT

15.17.2 REVENUE ANALYSIS

15.17.3 PRODUCT PORTFOLIO

15.17.4 RECENT DEVELOPMENT

15.18 DEMEDITEC DIAGNOSTICS GMBH

15.18.1 COMPANY SNAPSHOT

15.18.2 PRODUCT PORTFOLIO

15.18.3 RECENT DEVELOPMENT

15.19 DHN

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENT

15.2 DIAGNOSTIC IMAGING SYSTEMS

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENT

15.21 ESAOTE SPA

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

15.22 EUROFINS SCIENTIFIC

15.22.1 COMPANY SNAPSHOT

15.22.2 REVENUE ANALYSIS

15.22.3 PRODUCT PORTFOLIO

15.22.4 RECENT DEVELOPMENT

15.23 EVONIK ANIMAL NUTRITION

15.23.1 COMPANY SNAPSHOT

15.23.2 REVENUE ANALYSIS

15.23.3 1.1.3 PRODUCT PORTFOLIO

15.23.4 RECENT DEVELOPMENT

15.24 FUJIFILM HOLDINGS CORPORATION

15.24.1 COMPANY SNAPSHOT

15.24.2 REVENUE ANALYSIS

15.24.3 PRODUCT PORTFOLIO

15.24.4 RECENT DEVELOPMENT

15.25 GOLD STANDARD DIAGNOSTICS

15.25.1 COMPANY SNAPSHOT

15.25.2 PRODUCT PORTFOLIO

15.25.3 RECENT DEVELOPMENT

15.26 HALLMARQ VETERINARY IMAGING

15.26.1 COMPANY SNAPSHOT

15.26.2 PRODUCT PORTFOLIO

15.26.3 RECENT DEVELOPMENT

15.27 HEBEI VEYONG PHARMACEUTICAL CO., LTD.

15.27.1 COMPANY SNAPSHOT

15.27.2 PRODUCT PORTFOLIO

15.27.3 RECENT DEVELOPMENT

15.28 IBIS S.R.L.

15.28.1 COMPANY SNAPSHOT

15.28.2 PRODUCT PORTFOLIO

15.28.3 RECENT DEVELOPMENT

15.29 VIRBAC

15.29.1 COMPANY SNAPSHOT

15.29.2 REVENUE ANALYSIS

15.29.3 PRODUCT PORTFOLIO

15.29.4 RECENT DEVELOPMENT

15.3 VMRD, INC

15.30.1 COMPANY SNAPSHOT

15.30.2 PRODUCT PORTFOLIO

15.30.3 RECENT DEVELOPMENT

15.31 HESKA CORPORATION

15.31.1 COMPANY SNAPSHOT

15.31.2 REVENUE ANALYSIS

15.31.3 PRODUCT PORTFOLIO

15.31.4 RECENT DEVELOPMENT

15.32 KARYOPHARM

15.32.1 COMPANY SNAPSHOT

15.32.2 REVENUE ANALYSIS

15.32.3 PRODUCT PORTFOLIO

15.32.4 RECENT DEVELOPMENT

15.33 MERIDIAN BIOSCIENCE, INC

15.33.1 COMPANY SNAPSHOT

15.33.2 PRODUCT PORTFOLIO

15.33.3 RECENT DEVELOPMENT

15.34 NARANG MEDICAL LIMITED

15.34.1 COMPANY SNAPSHOT

15.34.2 PRODUCT PORTFOLIO

15.34.3 RECENT DEVELOPMENT

15.35 NEOGEN CORPORATION

15.35.1 COMPANY SNAPSHOT

15.35.2 REVENUE ANALYSIS

15.35.3 PRODUCT PORTFOLIO

15.35.4 RECENT DEVELOPMENT

15.36 NIPPON ZENYAKU KOGYO CO., LTD.

15.36.1 COMPANY SNAPSHOT

15.36.2 PRODUCT PORTFOLIO

15.36.3 RECENT DEVELOPMENT

15.37 VETDC

15.37.1 COMPANY SNAPSHOT

15.37.2 PRODUCT PORTFOLIO

15.37.3 RECENT DEVELOPMENT

15.38 NOVAVIVE INC.

15.38.1 COMPANY SNAPSHOT

15.38.2 PRODUCT PORTFOLIO

15.38.3 RECENT DEVELOPMENT

15.39 NUTRECO

15.39.1 COMPANY SNAPSHOT

15.39.2 PRODUCT PORTFOLIO

15.39.3 RECENT DEVELOPMENT

15.4 PLANMECA OY

15.40.1 COMPANY SNAPSHOT

15.40.2 PRODUCT PORTFOLIO

15.40.3 RECENT DEVELOPMENT

15.41 RANDOX LABORATORIES LTD.

15.41.1 COMPANY SNAPSHOT

15.41.2 PRODUCT PORTFOLIO

15.41.3 RECENT DEVELOPMENT

15.42 RINGPU BIOLOGY CO., LTD.

15.42.1 COMPANY SNAPSHOT

15.42.2 PRODUCT PORTFOLIO

15.42.3 RECENT DEVELOPMENT

15.43 SHENZHEN SONTU MEDICAL IMAGING EQUIPMENT CO., LTD

15.43.1 COMPANY SNAPSHOT

15.43.2 PRODUCT PORTFOLIO

15.43.3 RECENT DEVELOPMENT

15.44 THERMO FISHER SCIENTIFIC INC

15.44.1 COMPANY SNAPSHOT

15.44.2 REVENUE ANALYSIS

15.44.3 PRODUCT PORTFOLIO

15.44.4 RECENT DEVELOPMENT

15.45 TORIGEN PHARMACEUTICALS INC.

15.45.1 COMPANY SNAPSHOT

15.45.2 PRODUCT PORTFOLIO

15.45.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

List of Table

TABLE 1  NORTH AMERICA VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 2  NORTH AMERICA THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 3  NORTH AMERICA THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 4  NORTH AMERICA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 5  NORTH AMERICA ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 6  NORTH AMERICA PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 7  NORTH AMERICA ANALGESICS/ANTI INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 8  NORTH AMERICA AANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 9  NORTH AMERICA CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 10  NORTH AMERICA ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 11  NORTH AMERICA HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 12  NORTH AMERICA OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 13  NORTH AMERICA MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 14  NORTH AMERICA PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 15  NORTH AMERICA KAPPA AGONIST MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 16  NORTH AMERICA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018 2032 (USD THOUSAND)

TABLE 17  NORTH AMERICA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018 2032 (USD THOUSAND)

TABLE 18  NORTH AMERICA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018 2032 (USD THOUSAND)

TABLE 19  NORTH AMERICA ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 20  NORTH AMERICA PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 21  NORTH AMERICA VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 22  NORTH AMERICA BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 23  NORTH AMERICA MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 24  NORTH AMERICA MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 25  NORTH AMERICA ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 26  NORTH AMERICA AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 27  NORTH AMERICA VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 28  NORTH AMERICA FAT SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 29  NORTH AMERICA WATER SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 30  NORTH AMERICA ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 31  NORTH AMERICA PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 32  NORTH AMERICA FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 33  NORTH AMERICA MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 34  NORTH AMERICA MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 35  NORTH AMERICA PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 36  NORTH AMERICA CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 37  NORTH AMERICA TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 38  NORTH AMERICA PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 39  NORTH AMERICA FLAVORS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 40  NORTH AMERICA SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 41  NORTH AMERICA DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 42  NORTH AMERICA DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 43  NORTH AMERICA INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 44  NORTH AMERICA IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 45  NORTH AMERICA X RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 46  NORTH AMERICA ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 47  NORTH AMERICA COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 48  NORTH AMERICA MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 49  NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 50  NORTH AMERICA LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 51  NORTH AMERICA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 52  NORTH AMERICA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018 2032 (USD THOUSAND)

TABLE 53  NORTH AMERICA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 54  NORTH AMERICA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 55  NORTH AMERICA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 56  NORTH AMERICA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018 2032 (USD THOUSAND)

TABLE 57  NORTH AMERICA POINT OF CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 58  NORTH AMERICA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 59  NORTH AMERICA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018 2032 (USD THOUSAND)

TABLE 60  NORTH AMERICA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018 2032 (USD THOUSAND)

TABLE 61  NORTH AMERICA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 62  NORTH AMERICA URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 63  NORTH AMERICA REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 64  NORTH AMERICA REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 65  NORTH AMERICA REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 66  NORTH AMERICA KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 67  NORTH AMERICA REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 68  NORTH AMERICA VETERINARY MEDICINE MARKET, BY APPLICATION, 2018 2032 (USD THOUSAND)

TABLE 69  NORTH AMERICA BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 70  NORTH AMERICA BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 71  NORTH AMERICA CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 72  NORTH AMERICA CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 73  NORTH AMERICA HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 74  NORTH AMERICA HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 75  NORTH AMERICA ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 76  NORTH AMERICA ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 77  NORTH AMERICA FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 78  NORTH AMERICA FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 79  NORTH AMERICA AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 80  NORTH AMERICA AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 81  NORTH AMERICA BLUETONGUE IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 82  NORTH AMERICA BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 83  NORTH AMERICA OTHERS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 84  NORTH AMERICA OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 85  NORTH AMERICA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 86  NORTH AMERICA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 87  NORTH AMERICA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 88  NORTH AMERICA PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 89  NORTH AMERICA PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 90  NORTH AMERICA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018 2032 (USD THOUSAND)

TABLE 91  NORTH AMERICA RETAIL SALES IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 92  NORTH AMERICA RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 93  NORTH AMERICA OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 94  NORTH AMERICA ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 95  NORTH AMERICA DIRECT TENDER IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 96  NORTH AMERICA OTHERS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 97  NORTH AMERICA VETERINARY MEDICINE MARKET, BY END USER, 2018 2032 (USD THOUSAND)

TABLE 98  NORTH AMERICA VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 99  NORTH AMERICA VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 100  NORTH AMERICA VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018 2032 (USD THOUSAND)

TABLE 101  NORTH AMERICA VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 102  NORTH AMERICA VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 103  NORTH AMERICA ANIMAL AND VETERINARY FARMS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 104  NORTH AMERICA REFERENCE LABORATORIES IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 105  NORTH AMERICA ACADEMIC AND RESEARCH INSTITUTE IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 106  NORTH AMERICA POINT OF CARE TESTING/IN HOUSE TESTING IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 107  NORTH AMERICA OTHERS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 108  NORTH AMERICA VETERINARY MEDICINE MARKET, BY COUNTRY, 2018 2032 (USD THOUSAND)

TABLE 109  NORTH AMERICA VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 110  NORTH AMERICA THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 111  NORTH AMERICA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 112  NORTH AMERICA ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 113  NORTH AMERICA PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 114  NORTH AMERICA ANALGESICS/ANTI INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 115  NORTH AMERICA ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 116  NORTH AMERICA CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 117  NORTH AMERICA ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 118  NORTH AMERICA HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 119  NORTH AMERICA OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 120  NORTH AMERICA MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 121  NORTH AMERICA PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 122  NORTH AMERICA KAPPA AGONIST MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 123  NORTH AMERICA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018 2032 (USD THOUSAND)

TABLE 124  NORTH AMERICA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018 2032 (USD THOUSAND)

TABLE 125  NORTH AMERICA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018 2032 (USD THOUSAND)

TABLE 126  NORTH AMERICA ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 127  NORTH AMERICA PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 128  NORTH AMERICA VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 129  NORTH AMERICA BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 130  NORTH AMERICA MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 131  NORTH AMERICA MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 132  NORTH AMERICA ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 133  NORTH AMERICA AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 134  NORTH AMERICA VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 135  NORTH AMERICA FAT SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 136  NORTH AMERICA WATER SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 137  NORTH AMERICA ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 138  NORTH AMERICA PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 139  NORTH AMERICA FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 140  NORTH AMERICA MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 141  NORTH AMERICA MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 142  NORTH AMERICA PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 143  NORTH AMERICA CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 144  NORTH AMERICA TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 145  NORTH AMERICA PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 146  NORTH AMERICA FLAVORS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 147  NORTH AMERICA SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 148  NORTH AMERICA DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 149  NORTH AMERICA INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 150  NORTH AMERICA IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 151  NORTH AMERICA X RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 152  NORTH AMERICA ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 153  NORTH AMERICA COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 154  NORTH AMERICA MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 155  NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 156  NORTH AMERICA LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 157  NORTH AMERICA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 158  NORTH AMERICA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018 2032 (USD THOUSAND)

TABLE 159  NORTH AMERICA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 160  NORTH AMERICA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 161  NORTH AMERICA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 162  NORTH AMERICA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018 2032 (USD THOUSAND)

TABLE 163  NORTH AMERICA POINT OF CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 164  NORTH AMERICA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 165  NORTH AMERICA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018 2032 (USD THOUSAND)

TABLE 166  NORTH AMERICA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018 2032 (USD THOUSAND)

TABLE 167  NORTH AMERICA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 168  NORTH AMERICA URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 169  NORTH AMERICA REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 170  NORTH AMERICA REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 171  NORTH AMERICA REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 172  NORTH AMERICA KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 173  NORTH AMERICA REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 174  NORTH AMERICA VETERINARY MEDICINE MARKET, BY APPLICATION, 2018 2032 (USD THOUSAND)

TABLE 175  NORTH AMERICA BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 176  NORTH AMERICA CANINE ATOPIC DERMATITIS  IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 177  NORTH AMERICA HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 178  NORTH AMERICA ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 179  NORTH AMERICA FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 180  NORTH AMERICA AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 181  NORTH AMERICA BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 182  NORTH AMERICA OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 183  NORTH AMERICA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 184  NORTH AMERICA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 185  NORTH AMERICA PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 186  NORTH AMERICA VETERINARY MEDICINE MARKET, BY END USER, 2018 2032 (USD THOUSAND)

TABLE 187  NORTH AMERICA VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 188  NORTH AMERICA VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018 2032 (USD THOUSAND)

TABLE 189  NORTH AMERICA VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 190  NORTH AMERICA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018 2032 (USD THOUSAND)

TABLE 191  NORTH AMERICA RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 192  NORTH AMERICA OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 193  NORTH AMERICA ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 194  U.S. VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 195  U.S. THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 196  U.S. PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 197  U.S. ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 198  U.S. PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 199  U.S. ANALGESICS/ANTI INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 200  U.S. ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 201  U.S. CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 202  U.S. ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 203  U.S. HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 204  U.S. OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 205  U.S. MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 206  U.S. PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 207  U.S. KAPPA AGONIST MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 208  U.S. PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018 2032 (USD THOUSAND)

TABLE 209  U.S. PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018 2032 (USD THOUSAND)

TABLE 210  U.S. PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018 2032 (USD THOUSAND)

TABLE 211  U.S. ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 212  U.S. PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 213  U.S. VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 214  U.S. BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 215  U.S. MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 216  U.S. MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 217  U.S. ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 218  U.S. AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 219  U.S. VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 220  U.S. FAT SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 221  U.S. WATER SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 222  U.S. ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 223  U.S. PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 224  U.S. FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 225  U.S. MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 226  U.S. MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 227  U.S. PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 228  U.S. CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 229  U.S. TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 230  U.S. PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 231  U.S. FLAVORS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 232  U.S. SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 233  U.S. DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 234  U.S. INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 235  U.S. IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 236  U.S. X RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 237  U.S. ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 238  U.S. COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 239  U.S. MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 240  U.S. SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 241  U.S. LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 242  U.S. HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 243  U.S. HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018 2032 (USD THOUSAND)

TABLE 244  U.S. HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 245  U.S. CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 246  U.S. CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 247  U.S. CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018 2032 (USD THOUSAND)

TABLE 248  U.S. POINT OF CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 249  U.S. COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 250  U.S. COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018 2032 (USD THOUSAND)

TABLE 251  U.S. COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018 2032 (USD THOUSAND)

TABLE 252  U.S. COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 253  U.S. URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 254  U.S. REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 255  U.S. REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 256  U.S. REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 257  U.S. KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 258  U.S. REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 259  U.S. VETERINARY MEDICINE MARKET, BY APPLICATION, 2018 2032 (USD THOUSAND)

TABLE 260  U.S. BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 261  U.S. CANINE ATOPIC DERMATITIS  IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 262  U.S. HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 263  U.S. ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 264  U.S. FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 265  U.S. AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 266  U.S. BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 267  U.S. OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 268  U.S. VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 269  U.S. COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 270  U.S. PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 271  U.S. VETERINARY MEDICINE MARKET, BY END USER, 2018 2032 (USD THOUSAND)

TABLE 272  U.S. VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 273  U.S. VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018 2032 (USD THOUSAND)

TABLE 274  U.S. VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 275  U.S. VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018 2032 (USD THOUSAND)

TABLE 276  U.S. RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 277  U.S. OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 278  U.S. ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 279  CANADA VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 280  CANADA THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 281  CANADA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 282  CANADA ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 283  CANADA PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 284  CANADA ANALGESICS/ANTI INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 285  CANADA ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 286  CANADA CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 287  CANADA ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 288  CANADA HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 289  CANADA OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 290  CANADA MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 291  CANADA PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 292  CANADA KAPPA AGONIST MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 293  CANADA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018 2032 (USD THOUSAND)

TABLE 294  CANADA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018 2032 (USD THOUSAND)

TABLE 295  CANADA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018 2032 (USD THOUSAND)

TABLE 296  CANADA ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 297  CANADA PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 298  CANADA VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 299  CANADA BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 300  CANADA MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 301  CANADA MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 302  CANADA ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 303  CANADA AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 304  CANADA VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 305  CANADA FAT SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 306  CANADA WATER SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 307  CANADA ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 308  CANADA PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 309  CANADA FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 310  CANADA MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 311  CANADA MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 312  CANADA PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 313  CANADA CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 314  CANADA TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 315  CANADA PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 316  CANADA FLAVORS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 317  CANADA SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 318  CANADA DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 319  CANADA INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 320  CANADA IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 321  CANADA X RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 322  CANADA ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 323  CANADA COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 324  CANADA MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 325  CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 326  CANADA LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 327  CANADA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 328  CANADA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018 2032 (USD THOUSAND)

TABLE 329  CANADA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 330  CANADA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 331  CANADA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 332  CANADA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018 2032 (USD THOUSAND)

TABLE 333  CANADA POINT OF CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 334  CANADA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 335  CANADA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018 2032 (USD THOUSAND)

TABLE 336  CANADA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018 2032 (USD THOUSAND)

TABLE 337  CANADA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 338  CANADA URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 339  CANADA REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 340  CANADA REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 341  CANADA REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 342  CANADA KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 343  CANADA REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 344  CANADA VETERINARY MEDICINE MARKET, BY APPLICATION, 2018 2032 (USD THOUSAND)

TABLE 345  CANADA BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 346  CANADA CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 347  CANADA HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 348  CANADA ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 349  CANADA FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 350  CANADA AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 351  CANADA BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 352  CANADA OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 353  CANADA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 354  CANADA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 355  CANADA PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 356  CANADA VETERINARY MEDICINE MARKET, BY END USER, 2018 2032 (USD THOUSAND)

TABLE 357  CANADA VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 358  CANADA VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018 2032 (USD THOUSAND)

TABLE 359  CANADA VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 360  CANADA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018 2032 (USD THOUSAND)

TABLE 361  CANADA RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 362  CANADA OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 363  CANADA ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 364  MEXICO VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 365  MEXICO THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 366  MEXICO PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 367  MEXICO ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 368  MEXICO PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 369  MEXICO ANALGESICS/ANTI INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 370  MEXICO ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 371  MEXICO CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 372  MEXICO ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 373  MEXICO HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 374  MEXICO OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 375  MEXICO MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 376  MEXICO PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 377  MEXICO KAPPA AGONIST MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 378  MEXICO PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018 2032 (USD THOUSAND)

TABLE 379  MEXICO PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018 2032 (USD THOUSAND)

TABLE 380  MEXICO PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018 2032 (USD THOUSAND)

TABLE 381  MEXICO ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 382  MEXICO PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 383  MEXICO VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 384  MEXICO BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 385  MEXICO MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 386  MEXICO MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 387  MEXICO ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 388  MEXICO AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 389  MEXICO VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 390  MEXICO FAT SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 391  MEXICO WATER SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 392  MEXICO ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 393  MEXICO PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 394  MEXICO FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 395  MEXICO MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 396  MEXICO MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 397  MEXICO PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 398  MEXICO CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 399  MEXICO TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 400  MEXICO PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 401  MEXICO FLAVORS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 402  MEXICO SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 403  MEXICO DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 404  MEXICO INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 405  MEXICO IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 406  MEXICO X RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 407  MEXICO ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 408  MEXICO COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 409  MEXICO MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 410  MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 411  MEXICO LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 412  MEXICO HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 413  MEXICO HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018 2032 (USD THOUSAND)

TABLE 414  MEXICO HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 415  MEXICO CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 416  MEXICO CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 417  MEXICO CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018 2032 (USD THOUSAND)

TABLE 418  MEXICO POINT OF CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 419  MEXICO COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 420  MEXICO COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018 2032 (USD THOUSAND)

TABLE 421  MEXICO COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018 2032 (USD THOUSAND)

TABLE 422  MEXICO COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 423  MEXICO URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 424  MEXICO REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 425  MEXICO REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 426  MEXICO REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 427  MEXICO KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 428  MEXICO REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 429  MEXICO VETERINARY MEDICINE MARKET, BY APPLICATION, 2018 2032 (USD THOUSAND)

TABLE 430  MEXICO BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 431  MEXICO CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 432  MEXICO HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 433  MEXICO ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 434  MEXICO FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 435  MEXICO AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 436  MEXICO BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 437  MEXICO OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 438  MEXICO VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 439  MEXICO COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 440  MEXICO PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 441  MEXICO VETERINARY MEDICINE MARKET, BY END USER, 2018 2032 (USD THOUSAND)

TABLE 442  MEXICO VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 443  MEXICO VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018 2032 (USD THOUSAND)

TABLE 444  MEXICO VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 445  MEXICO VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018 2032 (USD THOUSAND)

TABLE 446  MEXICO RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 447  MEXICO OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 448  MEXICO ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

List of Figure

FIGURE 1  NORTH AMERICA VETERINARY MEDICINE MARKET: SEGMENTATION

FIGURE 2  NORTH AMERICA VETERINARY MEDICINE MARKET: DATA TRIANGULATION

FIGURE 3  NORTH AMERICA VETERINARY MEDICINE MARKET: DROC ANALYSIS

FIGURE 4  NORTH AMERICA VETERINARY MEDICINE MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5  NORTH AMERICA VETERINARY MEDICINE MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6  NORTH AMERICA VETERINARY MEDICINE MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7  NORTH AMERICA VETERINARY MEDICINE MARKET: DBMR MARKET POSITION GRID

FIGURE 8  NORTH AMERICA VETERINARY MEDICINE MARKET: END USER COVERAGE GRID

FIGURE 9  NORTH AMERICA VETERINARY MEDICINE MARKET: VENDOR SHARE ANALYSIS

FIGURE 10  NORTH AMERICA VETERINARY MEDICINE MARKET: SEGMENTATION

FIGURE 11  NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA VETERINARY MEDICINE MARKET AND ASIA PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 12  TWO SEGMENTS COMPRISE THE NORTH AMERICA VETERINARY MEDICINE MARKET, BY TYPE

FIGURE 13  EXECUTIVE SUMMARY

FIGURE 14  STRATEGIC DECISIONS

FIGURE 15  INCREASING PET OWNERSHIP BOOSTS DEMAND FOR VETERINARY SERVICES IS DRIVING THE GROWTH OF THE NORTH AMERICA VETERINARY MEDICINE MARKET FROM 2025 TO 2032

FIGURE 16  THERAPEUTIC SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA VETERINARY MEDICINE MARKET IN 2025 AND 2032

FIGURE 17  ASIA PACIFIC IS THE FASTEST GROWING REGION FOR THE NORTH AMERICA VETERINARY MEDICINE MARKET IN 2025 & 2032

FIGURE 18  DROC ANALYSIS

FIGURE 19  NORTH AMERICA VETERINARY MEDICINE MARKET: BY TYPE, 2024

FIGURE 20  NORTH AMERICA VETERINARY MEDICINE MARKET: BY TYPE, 2025 2032 (USD THOUSAND)

FIGURE 21  NORTH AMERICA VETERINARY MEDICINE MARKET: BY TYPE, CAGR (2025 2032)

FIGURE 22  NORTH AMERICA VETERINARY MEDICINE MARKET: BY TYPE, LIFELINE CURVE

FIGURE 23  NORTH AMERICA VETERINARY MEDICINE MARKET: BY APPLICATION, 2024

FIGURE 24  NORTH AMERICA VETERINARY MEDICINE MARKET: BY APPLICATION, 2025 2032 (USD THOUSAND)

FIGURE 25  NORTH AMERICA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2025 2032)

FIGURE 26  NORTH AMERICA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 27  NORTH AMERICA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2024

FIGURE 28  NORTH AMERICA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2025 2032 (USD THOUSAND)

FIGURE 29  NORTH AMERICA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2025 2032)

FIGURE 30  NORTH AMERICA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE

FIGURE 31  NORTH AMERICA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 32  NORTH AMERICA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2025 2032 (USD THOUSAND)

FIGURE 33  NORTH AMERICA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025 2032)

FIGURE 34  NORTH AMERICA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 35  NORTH AMERICA VETERINARY MEDICINE MARKET: BY END USER, 2024

FIGURE 36  NORTH AMERICA VETERINARY MEDICINE MARKET: BY END USER, 2025 2032 (USD THOUSAND)

FIGURE 37  NORTH AMERICA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2025 2032)

FIGURE 38  NORTH AMERICA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE

FIGURE 39  NORTH AMERICA VETERINARY MEDICINE MARKET: SNAPSHOT (2024)

FIGURE 40  NORTH AMERICA VETERINARY MEDICINE MARKET: COMPANY SHARE 2024 (%)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The North America veterinary medicine market size was valued at USD 19.17 billion in 2024.
The North America veterinary medicine market is to grow at a CAGR of 6.5% during the forecast period of 2025 to 2032.
The North America veterinary medicine market on the basis of type, application, animal type, end user, and distribution channel. On the basis of type, the market is segmented into therapeutics and diagnostics. On the basis of application the market is segmented into bacterial diseases, canine atopic dermatitis, heminthes infection, animal cancer, foot and mouth disease, autoimmune diseases, bluetongue and others. On the basis of animal type, the market is segmented into companion animals and production animal. On the basis of end user, the market is segmented into veterinary hospitals, veterinary clinics, animal and veterinary farms, reference laboratories, academic and research institute, point-of-care testing/in-house testing and others. On the basis of distribution channel, the market is segmented into retail sales and direct tender and others.
Companies such as Zoetis Services LLC (U.S.), Merck & Co., Inc. (U.S.), Elanco or its affiliates. (U.S.),C.H. Boehringer Ingelheim International GmbH and IDEXX LABORATORIES, INC(Germany) are the major companies in the Veterinary Medicine Market
In February 2023, Vetoquinol introduces Immun-C Aqua, an advanced water-soluble immune booster designed to enhance the health and resilience of aquatic species. This innovative formula strengthens disease resistance, improves overall vitality, and optimizes growth performance in fish and shrimp farming. By fortifying the immune system, Immun-C Aqua helps reduce mortality rates and enhances survival in challenging environments. With a scientifically developed composition, it ensures rapid absorption and effective action, contributing to sustainable and productive aquaculture. This launch underscores Vetoquinol’s commitment to providing high-quality, research-backed solutions for the aquaculture industry, supporting healthier aquatic livestock and improving farm profitability.
The countries covered in the veterinary medicine market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
U.S. is expected to dominate the North America veterinary medicine market due to technological advancements, strategic investments, and expanding pharmaceutical exports. Its competitive pricing and innovation in animal healthcare solutions are helping it gain a strong foothold, challenging local players and reshaping the region's veterinary landscape.
U.S. is expected to witness the highest CAGR in the veterinary medicine market. This growth is driven by aggressive healthcare investments, robust government support for innovation, and rapid advancements in treatment technologies. In addition, the expanding patient base and rising demand for cutting-edge therapies contribute significantly to this accelerated growth.
The major factors driving the growth of the veterinary medicine market are increasing pet ownership boosts demand for veterinary services.
The growing emphasis on smart cities and energy efficiency initiatives, backed by strong government support, is emerging as a pivotal trend driving the North America veterinary medicine market.
The primary challenges include challenges of regulatory compliance and complexity.
The therapeutics segment is expected to dominate the North America veterinary medicine market, holding a major market share in 2025.

Industry Related Reports

Browse Related Pages

Browse Related Blogs

Browse Related Infographics

Browse Related Press Release

Market Statistics

Banner
Testimonial
Image
Claudio Rondena Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future